Sarepta Therapeutics, Inc. vs UnitedHealth Group Incorporated — Stock Comparison

SRPT
Sarepta Therapeutics, Inc.
$21.49
▲ 2.92%
vs
UNH
UnitedHealth Group Incorporated
$368.78
▼ 0.46%
Q·Score Winner
UnitedHealth Group Incorporated
UNH6.3/10vs 4.4/10

Q·Score Breakdown

4.4
Bearish
Overall
6.3
Neutral
1.3
Quality
6.2
6.9
Health
5.3
3.3
Growth
5.1
6.7
Valuation
7.3
4.7
Sentiment
8.1
SRPT

Healthy balance sheet and financial position.

currently unprofitable (-32% margin).

UNH

82% of 28 covering analysts have a positive rating.

limited growth momentum.

Analyst Consensus

HOLD
Target $21.78 (+1.4%)
23 analysts
BUY
Target $387.27 (+5.0%)
26 analysts

Fundamentals

SRPT
UNH
Trailing P/E
27.9×
7.2×
Forward P/E
17.8×
-32.5%
Profit Margin
2.7%
-7.4%
Gross Margin
18.8%
-53.5%
ROE
12.2%
-32.7%
Revenue Growth
2.0%
Earnings Growth
0.7%
0.28
Beta
0.41
Price / Book
$2.3B
Market Cap
$334.9B
$10 – $65
52-Week Range
$235 – $410

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →